首页> 美国卫生研究院文献>Oncotarget >A new predictive model combined of tumor size lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer

【2h】

A new predictive model combined of tumor size lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer

机译：肿瘤大小淋巴结计数和淋巴管浸润相结合的新预测模型对淋巴结阴性胃癌患者的生存预后

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundVarious factors may affect the clinical prognosis of lymph node-negative gastric cancer (GC) patients. This study aimed to provide evaluable prognostic information of combination of tumor size (Ts), lymph nodes count (LNs) and lymphovascular invasion (LVI) in lymph node-negative GC patients.

机译：背景各种因素可能会影响淋巴结阴性胃癌（GC）患者的临床预后。这项研究旨在为淋巴结阴性的GC患者提供肿瘤大小（Ts），淋巴结计数（LNs）和淋巴管浸润（LVI）组合的可评估预后信息。

著录项

期刊名称 Oncotarget
作者
Lin-Yong Zhao; Xiao-Long Chen; Yi-Gao Wang; Yue Xin; Wei-Han Zhang; Yin-Su Wang; Xin-Zu Chen; Kun Yang; Kai Liu; Lian Xu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu;
展开▼
作者单位

展开▼
年(卷),期 2016(7),44
年度 2016
页码 72300–72310
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;细胞生物学;
关键词
predictive model gastric cancer tumor size lymphovascular invasion lymph nodes count;

机译：预测模型;胃癌;肿瘤大小;淋巴管浸润;淋巴结计数;

相似文献

外文文献
中文文献
专利

1. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial [J] . Christian Bolenz, Edwin Herrmann, Patrick J. Bastian, BJU International . 2010,第4期

机译：淋巴结浸润是根治性膀胱切除术治疗的淋巴结阴性尿路上皮膀胱癌患者肿瘤学结局的独立预测因子：一项多中心验证试验
2. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial. [J] . Bolenz C, Herrmann E, Bastian PJ, BJU international . 2010,第4期

机译：淋巴血管入侵是由自由基膀胱切除术治疗的淋巴结阴性尿道膀胱癌患者的肿瘤患者的独立预测因素：多期验证试验。
3. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. [J] . Biffi R, Botteri E, Cenciarelli S, European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2011,第4期

机译：淋巴结清扫延长的淋巴结阴性胃癌患者切除淋巴结数目对生存的影响。
4. Central Lymph Node Metastasis as a Predictor for Lateral Lymph Node Metastasis in Clinically Node-Negative T3 and T4 Papillary Thyroid Carcinoma [C] . Zhe Han, Shuai Xue, Peisong Wang, International Conference on Information Technology in Medicine and Education . 2018

机译：中央淋巴结转移作为临床节点阴性T3和T4乳头状甲状腺癌中侧淋巴结转移的预测因子
5. Evaluation of pathologic parameters and published nomograms in predicting non-sentinel lymph node metastases in female breast cancer patients with positive sentinel lymph nodes. [D] . Murch, Lisa Elaine. 2007

机译：在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
6. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance Epidemiology and End Results (SEER) data validation [O] . Nannan Zhang, Huihui Bai, Jingyu Deng, 2020

机译：检查淋巴结计数对节点阴性阶段III胃癌患者分期和长期存活的影响：使用中国多机构登记处的回顾性研究具有监测流行病学和最终结果（SEER）数据验证
7. Table 5.5.a.1 Tumor size and treatment (rate of resectability) Figure 5.5.a.2 Cumulative survival of the patients after pancreatectomy for TS1 cancer according to residual tumors Figure 5.5.a.3 Cumulative survival of the patients with TS1 cancer according to extent of lymph node dissection Figure 5.5.a.4 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.5 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.6 Combined resection of peripancreatic plexus when there is no plexus infiltration and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.7 Combined resection of artery and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.8 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.9 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head [O] . 2007

机译：表5.5.a.1肿瘤大小和治疗（重新切性率）图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度，TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后，患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时，围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后，患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头

A new predictive model combined of tumor size lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer

摘要

著录项

相似文献

相关主题

期刊订阅